Papers on HbA1c <7%
106 papers8 new in 30 days
Tuesday, October 27
Research Square
Factors associated with hypertension among diabetic patients at two tertiary Hospitals in Rwanda: a case-control study
Preprint: case-control study of 400 peopleHypertension
Monday, October 26
Diseases
Real-World Pharmacological Patterns and Residual Cardiometabolic Risk in Patients with Type 2 Diabetes in Romania
Cross-sectional study of 232 peopleType 2 diabetes
ESC Congress 2026 Abstract
Cardiometabolic risk factor management and adherence to antihypertensive therapy in patients with severe obesity prior and after bariatric surgery: a cohort study
Cohort study of 64 peopleSevere obesity
ESC Congress 2026 Abstract
Cardiac rehabilitation and secondary prevention goals one year after myocardial infarction
Cohort study of 250 peopleCardiac rehabilitation
ESC Congress 2026 Abstract
Early detection and optimal management of cardiorenal metabolic syndrome to prevent heart failure in the population with coronary heart disease: results from INTERASPIRE survey
Cohort study of 4,259 peopleMetabolic syndrome
Tuesday, October 20
Revista Medica de Chile
Effectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus
Non-randomized trial in 104 peopleSemaglutide
Monday, October 12
Alzheimer's & Dementia
The effects of improved access to diabetes medications on risk of Alzheimer's disease and related dementias
Computational studyAlzheimer's disease and related dementias
Tuesday, September 29
Diabetes Therapy
Combined Semaglutide and Sodium-Glucose Cotransporter-2 Inhibitor Use and Metabolic Outcomes in Chinese Adults With Diabetes: Post Hoc Analysis
Cohort study of 11,361 peopleSGLT2 inhibitors
Tuesday, September 22
Diabetes, Obesity & Metabolism
Oral Semaglutide in Routine Clinical Practice: 24-Month Real-World Effectiveness, Persistence and Safety in Adults With Type 2 Diabetes
Cohort study of 232 peopleSemaglutide
Friday, September 18
Journal of the American Heart Association
Association of F11 Gene Variants With Cardiovascular Events and Cardiac Function
Cohort study of 408,642 peoplePopulations
Saturday, August 29
European Heart Journal
ESC Guidelines on prevention and rehabilitation in coronary heart disease and current practice: the EUROASPIRE VI survey
Cohort study of 8,590 peopleCoronary artery disease
Thursday, August 20
Monday, August 3
The Journal of the Association of Physicians of India
Semaglutide in Practice: Insights from a Retrospective Case Series at a Jharkhand Tertiary Care Hospital
Cohort study of 60 peopleSemaglutide
Friday, July 31
Thursday, July 30
Frontiers in Artificial Intelligence
Machine learning algorithms for predicting glycemic control and weight loss outcomes in GLP-1 receptor agonist users
Cohort study of 11,420 peopleBiomarkers
Tuesday, July 7
Scientific Reports
Serum uric acid levels and mortality in diabetic patients with chronic kidney disease
Cohort study of 672 peopleChronic kidney disease
Monday, July 6
Endocrinology Research and Practice
Evaluation of Sarcopenia in Overweight and Middle-Aged Patients with Diabetes and Its Association with Poor Glycemic Control
Study in peoplePopulations
Monday, June 22
Acta Diabetologica
Diabetes, prediabetes, and mild cognitive impairment among older adults: the Hitachi Health Study II
Study in peoplePopulations
Saturday, June 6
ADA Scientific Sessions 2026 Abstract
Effectiveness and Safety of Adjunctive Therapy in Classic Type 1 Diabetes: A Real-World Cohort Study
Cohort study of 312 peopleType 1 diabetes
ADA Scientific Sessions 2026 Abstract
Cardiometabolic Outcomes in Adults with T2D Treated with 1 mg Semaglutide Who Titrate to 2 mg Semaglutide vs. Switch to Tirzepatide
Cohort study of 64,888 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Semaglutide Improves Postprandial Glucose Metabolism after Spinal Cord Injury: A First Mechanistic Study
Non-randomized trial in 5 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Semaglutide Improves Tissue-Specific Insulin Action and Reduces Liver Fat in Type 2 Diabetes with Spinal Cord Injury
Non-randomized trial in 5 peopleSemaglutide
ADA Scientific Sessions 2026 Abstract
Real-World Effectiveness and Safety of Dapagliflozin/Glimepiride/Metformin Fixed-Dose Combinations (FDC) in Indian Adults with Type 2 Diabetes Mellitus (T2DM): Insights from BENEFACTOR Study
Cohort study of 3,770 peopleType 2 diabetes
ADA Scientific Sessions 2026 Abstract
Impact and Effectiveness of Once-Weekly Semaglutide in Achieving Glycemic Targets among Public Health Care Patients with Type 2 Diabetes in Chile: A Multicenter Prospective Study
Non-randomized trial in 104 peopleSemaglutide
Friday, June 5
ADA Scientific Sessions 2026 Abstract
GLP-1 Use in Type 1 Diabetes Patients: Assessing Changes in HbA1c, Body Weight, and Cardiovascular Disease Risk Reduction
Cohort study of 623 peopleType 1 diabetes
ADA Scientific Sessions 2026 Abstract
Early Metabolic and Hepatic Benefits of Tirzepatide in Indian Adults with Type 2 Diabetes: Insights from Real-World Practice
Cohort study of 71 peopleTirzepatide
Monday, June 1
Friday, May 1
European Heart Journal Supplements
REAL–WORLD IMPLEMENTATION OF AN INTEGRATED CARDIO–DIABETOLOGY PATHWAY: A 1.5 YEARS EXPERIENCE IN CARDIOVASULAR RISK PROFILING AND MANAGEMENT
Study in peopleInterventions